Back
Range Cancer Therapeutics ETF Stock Predictions
Sponsored
CNCR
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
CNCR
Range Cancer Therapeutics ETF
Last Price:
13.62
Seasonality Move:
2.55%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Range Cancer Therapeutics ETF Stock Forecast
- Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically fallen by 5.2% based on the past 9 years of stock performance.
- Range Cancer Therapeutics ETF has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Range Cancer Therapeutics ETF Stock Undervalued?
The current Range Cancer Therapeutics ETF [CNCR] share price is $13.56. The Score for CNCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal. - CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Range Cancer Therapeutics ETF Stock Go Up Next Year?
- Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically fallen by 5.2% based on the past 9 years of stock performance.
Range Cancer Therapeutics ETF Stock Rating
Sell
47
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF overpriced?
- Range Cancer Therapeutics ETF has fallen lower in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Range Cancer Therapeutics ETF Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:
52-Week Data
52-Week High:
17.96
52-Week Low:
10.49
Prediction Charts
Market Cap:
0
Price in USD:
13.56
Volume:
3.56K
Beta:
1.11
Technical Analysis
SMA50:
14.86
SMA100:
14.77
SMA200:
15.05
52-Wk Change:
29.2%
Stock Predictions
-
Is Range Cancer Therapeutics ETF stock public?
Yes, Range Cancer Therapeutics ETF is a publicly traded company. -
What is the Range Cancer Therapeutics ETF stock quote today?
The Range Cancer Therapeutics ETF stock price is 13.56 USD today. -
How to buy Range Cancer Therapeutics ETF stock online?
You can buy Range Cancer Therapeutics ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-5 | 15.01 | 15.16 | 15.16 | 15.01 |
Nov-6 | 15.59 | 15.59 | 15.73 | 15.46 |
Nov-7 | 15.73 | 15.80 | 15.91 | 15.73 |
Nov-8 | 15.70 | 15.72 | 15.72 | 15.56 |
Nov-11 | 15.94 | 15.74 | 15.94 | 15.59 |
Nov-12 | 15.53 | 15.09 | 15.53 | 15.29 |
Nov-13 | 15.34 | 14.80 | 15.34 | 14.94 |
Nov-14 | 14.55 | 14.25 | 14.59 | 14.42 |
Nov-15 | 14.25 | 13.39 | 14.25 | 13.45 |
Nov-18 | 13.61 | 13.35 | 13.61 | 13.30 |
Nov-19 | 13.20 | 13.43 | 13.51 | 13.20 |
Nov-20 | 13.27 | 13.42 | 13.46 | 13.25 |
Nov-21 | 13.32 | 13.22 | 13.41 | 13.09 |
Nov-22 | 13.28 | 13.56 | 13.70 | 13.28 |
Range Cancer Therapeutics ETF Earnings
Data Unavailable
Range Cancer Therapeutics ETF Forecast Revenue Growth
Data Unavailable
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.